As of 2025-04-29, the Relative Valuation of Medipharm Labs Corp (LABS.TO) is (0.58) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 CAD, the upside of Medipharm Labs Corp based on Relative Valuation is -743.3%.
The range of the Relative Valuation is (0.56) - (0.60) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 24.4x | 23.2x |
| Forward P/E multiples | 20.3x - 23.3x | 21.8x |
| Fair Price | (0.56) - (0.60) | (0.58) |
| Upside | -726.8% - -767.5% | -743.3% |
| Date | P/E |
| 2025-04-22 | -3.49 |
| 2025-04-21 | -3.30 |
| 2025-04-17 | -3.30 |
| 2025-04-16 | -3.30 |
| 2025-04-15 | -3.30 |
| 2025-04-14 | -3.30 |
| 2025-04-11 | -3.30 |
| 2025-04-10 | -3.11 |
| 2025-04-09 | -3.30 |
| 2025-04-08 | -3.30 |
| 2025-04-07 | -3.30 |
| 2025-04-04 | -3.49 |
| 2025-04-03 | -3.69 |
| 2025-04-02 | -3.88 |
| 2025-04-01 | -3.88 |
| 2025-03-31 | -3.88 |
| 2025-03-28 | -3.88 |
| 2025-03-27 | -3.88 |
| 2025-03-26 | -3.88 |
| 2025-03-25 | -3.88 |
| 2025-03-24 | -4.46 |
| 2025-03-21 | -4.27 |
| 2025-03-20 | -4.08 |
| 2025-03-19 | -3.49 |
| 2025-03-18 | -3.49 |
| 2025-03-17 | -3.49 |
| 2025-03-14 | -3.49 |
| 2025-03-13 | -3.30 |
| 2025-03-12 | -3.30 |
| 2025-03-11 | -3.11 |
| 2025-03-10 | -2.72 |
| 2025-03-07 | -2.91 |
| 2025-03-06 | -3.11 |
| 2025-03-05 | -2.91 |
| 2025-03-04 | -2.91 |
| 2025-03-03 | -2.91 |
| 2025-02-28 | -2.91 |
| 2025-02-27 | -3.11 |
| 2025-02-26 | -2.72 |
| 2025-02-25 | -2.72 |
| 2025-02-24 | -2.52 |
| 2025-02-21 | -2.52 |
| 2025-02-20 | -2.72 |
| 2025-02-19 | -2.52 |
| 2025-02-18 | -2.52 |
| 2025-02-14 | -2.72 |
| 2025-02-13 | -2.52 |
| 2025-02-12 | -2.52 |
| 2025-02-11 | -2.52 |
| 2025-02-10 | -2.72 |